Yong Yu, SVP, Clinical Development at GENELUX Corp (GNLX), sold 906 shares at $2.42 ($2K) on 2026-03-24, disclosed to the SEC on 2026-03-26.
Open-market sale of $2k GNLX by SVP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $16K | — | Filing → |
| GNLX | SELL | 2025-05-13 | $16K | — | Filing → |